Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage. (avaa uuden ikkunan)

Brady KM, Easley RB, Tobias JD.

Lähde‎: Paediatr Anaesth 2006;16(10):1042-6.

Arkistoitu‎: PubMed 16972833

DOI‎: 10.1111/j.1460-9592.2006.02039.x

https://www.ncbi.nlm.nih.gov/pubmed/16972833 (avaa uuden ikkunan)

The use of recombinant activated factor VII in the treatment of massive pulmonary hemorrhage in a preterm infant. (avaa uuden ikkunan)

Cetin H, Yalaz M, Akisu M, Karapinar DY, Kavakli K, Kultursay N.

Lähde‎: Blood Coagul Fibrinolysis 2006;17(3):213-6.

Arkistoitu‎: PubMed 16575260

DOI‎: 10.1097/01.mbc.0000220245.20036.2d

https://www.ncbi.nlm.nih.gov/pubmed/16575260 (avaa uuden ikkunan)

The use of recombinant activated factor VII to control bleeding in a preterm infant undergoing exploratory laparotomy. (avaa uuden ikkunan)

Chuansumrit A, Nuntnarumit P, Okascharoen C, Teeraratkul S, Suwansingh S, Supapannachart S.

Lähde‎: Pediatrics 2002;110(1 Pt 1):169-71.

Arkistoitu‎: PubMed 12093965

https://www.ncbi.nlm.nih.gov/pubmed/12093965 (avaa uuden ikkunan)

Recombinant activated factor VIIa (rFVIIa) treatment in very-low-birth-weight (VLBW) premature infants with acute pulmonary hemorrhage: a single-center, retrospective study. (avaa uuden ikkunan)

Cosar H, Isik H, Cakır SC, Yar N, Goksen B, Tokbay H, Kertmen H, Erdoğan N, Durak I.

Lähde‎: Paediatr Drugs 2017;19(1):53-8.

Arkistoitu‎: PubMed 27826851

DOI‎: 10.1007/s40272-016-0203-3

https://www.ncbi.nlm.nih.gov/pubmed/27826851 (avaa uuden ikkunan)

Recombinant activated factor VIIa treatment for refractory hemorrhage in infants. (avaa uuden ikkunan)

Dang CN, Katakam LI, Smith PB, Cotten CM, Goldberg RN, Chandler N, Thornburg CD, Bidegain M.

Lähde‎: J Perinatol 2011;31(3):188-92.

Arkistoitu‎: PubMed 20671714

DOI‎: 10.1038/jp.2010.85

https://www.ncbi.nlm.nih.gov/pubmed/20671714 (avaa uuden ikkunan)

Use of recombinant factor VIIa in infants with severe coagulopathy. (avaa uuden ikkunan)

Fontaine MJ, Lazarchick J, Taylor S, Annibale D.

Lähde‎: J Perinatol 2004;24(5):310-1.

Arkistoitu‎: PubMed 15116125

DOI‎: 10.1038/sj.jp.7211086

https://www.ncbi.nlm.nih.gov/pubmed/15116125 (avaa uuden ikkunan)

Predicting response to rFVIIa in neonates with intractable bleeding or severe coagulation disturbances. (avaa uuden ikkunan)

Gkiougki E, Mitsiakos G, Chatziioannidis E, Papadakis E, Nikolaidis N.

Lähde‎: J Pediatr Hematol Oncol 2013;35(3):221-6.

Arkistoitu‎: PubMed 23511491

DOI‎: 10.1097/MPH.0b013e318286d27e

https://www.ncbi.nlm.nih.gov/pubmed/23511491 (avaa uuden ikkunan)

Successful use of recombinant activated FVII and aminocaproic acid in four neonates with life-threatening hemorrhage. (avaa uuden ikkunan)

Grizelj R, Vuković J, Filipović-Grčić B, Šarić D, Luetić T.

Lähde‎: Blood Coagul Fibrinolysis 2006;17(5):413-5.

Arkistoitu‎: PubMed 16788319

DOI‎: 10.1097/01.mbc.0000233373.71970.6f

https://www.ncbi.nlm.nih.gov/pubmed/16788319 (avaa uuden ikkunan)

Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass. (avaa uuden ikkunan)

Guzzetta NA, Huch S, Fernandez JD, Tosone SR, Miller BE.

Lähde‎: Paediatr Anaesth 2009;19(4):364-70.

Arkistoitu‎: PubMed 19143947

DOI‎: 10.1111/j.1460-9592.2008.02905.x

https://www.ncbi.nlm.nih.gov/pubmed/19143947 (avaa uuden ikkunan)

The use of recombinant factor VIIa for severe intractable bleeding during spine surgery. (avaa uuden ikkunan)

Kaw LL Jr, Coimbra R, Potenza BM, Garfin SR, Hoyt DB.

Lähde‎: Spine 2004;29(12):1384-7.

Arkistoitu‎: PubMed 15187645

https://www.ncbi.nlm.nih.gov/pubmed/15187645 (avaa uuden ikkunan)

Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases. (avaa uuden ikkunan)

Mitsiakos G, Papaioannou G, Giougi E, Karagianni P, Garipidou V, Nikolaidis N.

Lähde‎: J Pediatr Hematol Oncol 2007;29(3):145-50.

Arkistoitu‎: PubMed 17356391

DOI‎: 10.1097/MPH.0b013e3180335bcb

https://www.ncbi.nlm.nih.gov/pubmed/17356391 (avaa uuden ikkunan)

Treatment of severe pulmonary hemorrhage with activated recombinant factor VII (rFVIIa) in very low birth weight infants. (avaa uuden ikkunan)

Olomu N, Kulkarni R, Manco-Johnson M.

Lähde‎: J Perinatol 2002;22(8):672-4.

Arkistoitu‎: PubMed 12478454

DOI‎: 10.1038/sj.jp.7210787

https://www.ncbi.nlm.nih.gov/pubmed/12478454 (avaa uuden ikkunan)

Thrombotic events in neonates receiving recombinant factor VIIa or fresh frozen plasma. (avaa uuden ikkunan)

Puetz J, Darling G, Brabec P, Blatny J, Mathew P.

Lähde‎: Pediatr Blood Cancer 2009;53(6):1074-8.

Arkistoitu‎: PubMed 19621430

DOI‎: 10.1002/pbc.22160

https://www.ncbi.nlm.nih.gov/pubmed/19621430 (avaa uuden ikkunan)